Christopher W. Krueger - 17 Dec 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Chief Business Officer
Signature: /s/ Christopher Krueger
Issuer symbol: VTYX
Transactions as of: 17 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 20 Dec 2022, 18:57:19 UTC
Previous filing: 15 Dec 2022
Next filing: 23 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VTYX	Common Stock	Options Exercise	$0	+10,480	+3.8%	$0.000000	286,324	17 Dec 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Restricted Stock Units	Options Exercise	$0	-10,480	-25%	$0.000000	31,437	17 Dec 2022	Common Stock	10,480		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
F2	Includes 2,773 shares of Common Stock acquired on May 16, 2022 and 379 shares of Common Stock acquired on November 15, 2022, through the Issuer's 2021 Employee Stock Purchase Plan.
F3	Subject to the reporting person's continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through such applicable vesting date, twenty five percent (25%) of the RSUs subject to the award shall vest on the one (1) year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the RSUs subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean December 17, 2021.